Drug-induced Liver Injury from Intravenous Immunoglobulin for Prevention of Recurrent Gestational Alloimmune Liver Disease: A Clinical Catch-22
Saved in:
Main Authors: | Jessica A. Meyer (Author), Jenna S. Silverstein (Author), Kristen M. Thomas (Author), Sara G. Brubaker (Author), Judith L. Chervenak (Author) |
---|---|
Format: | Book |
Published: |
Thieme Medical Publishers, Inc.,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of Intravenous Immunoglobulin/Exchange Transfusion Therapy on Gestational Alloimmune Liver Disease
by: Pai-Jui Yeh, et al.
Published: (2021) -
Intravenous immunoglobulin induced pancytopenia while preventing development of gestational alloimmune liver disease: A case report
by: Minhazur Sarker, et al.
Published: (2022) -
Neonatal hemochromatosis attributed to gestational alloimmune liver disease treated with intravenous immunoglobulin and exchange transfusion therapy: an evidence-based case report
by: Adhi Teguh Perma Iskandar, et al.
Published: (2021) -
Successful pregnancy outcomes following intravenous immunoglobulin treatment in a woman with a previous fetal death in utero due to gestational alloimmune liver disease: A case report
by: Rebecca Moorhead, et al.
Published: (2022) -
Neonatal Liver Failure and Congenital Cirrhosis due to Gestational Alloimmune Liver Disease: A Case Report and Literature Review
by: Carolina Roos Mariano da Rocha, et al.
Published: (2017)